DxLiquid

Discover the next level of cancer care with our liquid biopsy products. Our comprehensive product line, including DxLiquid Pan100 and DxLiquid TMB500, targets somatic mutations through ctDNA analysis. We offer valuable support in treatment selection, response monitoring, and recurrence detection,
ensuring optimal management for cancer patients.

DxLiquid (All-In-One)

DxLiquid (All-In-One)

Probe Mix (Pan100)

Probe Mix (Pan100)

Probe Mix (TMB500)

Probe Mix (TMB500)

Magnetic Circulating DNA Maxi Reagent

 Magnetic Circulating DNA Maxi Reagent

Workflow

Dxome Solution

  • sample collection

    Sample
    Collection

  • arrow
  • sample Preparation

    Sample
    Preparation

  • arrow
  • Target Enrichment

    Target
    Enrichment

  • arrow
  • Sequencing

    Sequencing

  • arrow
  • Analysis & Report

    Analysis &
    Report

Bioinformatics Software

  • High Precision
    High Precision

    Utilizing state-of-the-art algorithms, our software accurately analyzes tumor DNA from blood samples, ensuring precise detection of genetic mutations.

  • UMI-Free
    UMI-Free

    Our proprietary core algorithms enable comparable or superior performance without requiring Unique Molecular Identifiers (UMIs).

  • Continuous Updates
    Continuous Updates

    Benefit from regular software updates that incorporate the latest advancements in genomic research, ensuring access to the most up-to-date analysis tools and features.

  • Comprehensive Annotation
    Comprehensive Annotation

    Users are able to view all the information at a single glance allowing examination of crucial information according to ASCO, AMP & CAP guidelines.

DxLiquid Products

Discover the unparalleled advantages of DxLiquid, an innovative blood-based test for diagnosing and monitoring various cancers.

Portfolio

  • Product
    Genes
  • Product

    Prostate 

    Genes

    18
  • Product

    TMB500 

    Genes

    540
  • *Gene numbers may be updated
  • 01

    Non-Invasive Testing

    Conducted using a simple blood sample, DxLiquid is less invasive compared to traditional tissue biopsies, minimizing discomfort for patients.

  • 02

    Real-Time Monitoring of Recurrence and Metastasis

    Monitor genetic changes in tumors in real-time, allowing for the evaluation of treatment effectiveness and early detection of recurrence.

  • 03

    Early Diagnosis

    Detect the presence of early-stage cancers, enabling prompt treatment initiation and improving patient outcomes.

  • 04

    Comprehensive Cancer Analysis

    DxLiquid offers a thorough analysis of multiple cancer types, detecting a wide range of tumor markers in a single test.

  • 05

    Predictive Treatment Response

    Analysis of the genetic characteristics of the tumor allows prediction of how patients will respond to specific treatments, facilitating personalized treatment plans.

  • 06

    Rapid Results

    Receive quick test results, enabling fast diagnosis and timely treatment planning.

스크롤 맨위로 가기